UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008042
Receipt number R000009472
Scientific Title Prospective analysis of ComparIson of pReventive effect on CardiovascuLar Events with different statin therapy (P-CIRCLE)
Date of disclosure of the study information 2012/05/28
Last modified on 2015/06/01 07:09:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective analysis of ComparIson of pReventive effect on CardiovascuLar Events with different statin therapy
(P-CIRCLE)

Acronym

Prospective analysis of ComparIson of pReventive effect on CardiovascuLar Events with different statin therapy
(P-CIRCLE)

Scientific Title

Prospective analysis of ComparIson of pReventive effect on CardiovascuLar Events with different statin therapy
(P-CIRCLE)

Scientific Title:Acronym

Prospective analysis of ComparIson of pReventive effect on CardiovascuLar Events with different statin therapy
(P-CIRCLE)

Region

Japan


Condition

Condition

Patients with coronary artery disease who underwent PCI

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To compare the preventive effect on cardiovascular events between atorvastatin and pitavastatin.
The patients with baseline HDL-C<45mg/dL are defined as prespecified subgroup.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Composite cardiovascular events
Occurrence of one of following events
1.Cardiovascular death
2.Non-fatal Myocardial Infarction (MI)
3.Non-fatal Cerebral Infarction (CI)
4.Repeated revascularization including bypass surgery, target lesion revascularization and repeated PCI for de novo lesion

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Pitavastatin 2~4mg daily

Interventions/Control_2

Atorvastatin 10~20mg daily

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Patients with hypercholesterolemia
who satisfied each criteria below
-LDL-C level is equal or greater than 100 mg/dL
-requiring cholesterol lowering drugs judged by attending physicians
2.Patients given written informed consent

Key exclusion criteria

1.Patients who met contraindication of LIVALO tablet below
- Patients who have hypersensitivity to LIVALO tablet
-Patients who have severe liver dysfunction or biliary atresia.
-Co-administration with cyclosporine
-Women who are pregnant or may become pregnant or nursing mothers
2.Patients who meet contraindication of LIPITOL tablet below
- Patients who have hypersensitivity to LIPITOL tablet
-Patients with the following diseases considered to be associated with defective hepatic metabolism: acute hepatitis, acute exacerbation of chronic hepatitis, liver cirrhosis, hepatic carcinoma and/or icterus
-Women who are pregnant or may become pregnant or nursing mothers
3.Patients with hepatic disorders (ALT or AST level is equal or greater than 100IU/L)
4.Patients who are ineligible in the opinion of the investigator

Target sample size

660


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takao Maruyama

Organization

Kawasaki Hospital

Division name

Department of Cardiology

Zip code


Address

3-3-1 Higashiyama-cho, Hyogo-ku, Kobe

TEL

078-511-3131

Email

maruyama_takao@kawasaki-hospital-kobe.or.jp


Public contact

Name of contact person

1st name
Middle name
Last name Takao Maruyama

Organization

Kawasaki Hospital

Division name

Department of Cardiology

Zip code


Address

3-3-1 Higashiyama-cho, Hyogo-ku, Kobe

TEL

078-511-3131

Homepage URL


Email

maruyama_takao@kawaswaki-hospital-kobe.or.jp


Sponsor or person

Institute

Kawasaki Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

医療法人 川崎病院(兵庫県)


Other administrative information

Date of disclosure of the study information

2012 Year 05 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2012 Year 04 Month 23 Day

Date of IRB


Anticipated trial start date

2012 Year 06 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 05 Month 28 Day

Last modified on

2015 Year 06 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009472


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name